<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02556580</url>
  </required_header>
  <id_info>
    <org_study_id>Albumin April 2015</org_study_id>
    <nct_id>NCT02556580</nct_id>
  </id_info>
  <brief_title>Volume Kinetics for 20% Albumin in Different Clinical Situations</brief_title>
  <acronym>Albumin</acronym>
  <official_title>Volume Kinetics for 20% Albumin in Conscious and Anesthetized Humans With and Without Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sodertalje Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sodertalje Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine the degree of plasma volume expansion and the half-life of the
      plasma volume expansion when 3 mL/kg of hyperoncotic (20%) albumin if infused over 30 minutes
      in conscious healthy volunteers, in patients undergoing surgery under general anesthesia, and
      on the day after major surgery when the patient is in a post surgical inflammatory state. The
      study also examines the increase in the plasma colloid osmotic pressure as a result of this
      infusion and its possible influence on markers of kidney damage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      15 volunteers, 15 patients undergoing surgery and 15 patients in the post-surgical phase will
      be recruited for this study because they have different degrees of vasodilatation and
      inflammation, which are factors of potential importance to the effectiveness of plasma volume
      expansion with albumin 20%. Hyperoncotic albumin should logically recruit fluid from the
      interstitial fluid space, but this possibility has recently been questioned in the &quot;revised
      Starling equation&quot;.

      The degree of plasma volume expansion and also the half-life will be estimated by population
      volume kinetics which uses serial analyses of the blood hemoglobin concentration and a
      summary measure of the excreted urine during the 5-hour experiment to calculate these outcome
      measures.

      There is a risk that hyperoncotic solutions cause pre-renal anuria due to the rise in plasma
      oncotic pressure. As a safety measure we will assess the plasma oncotic pressure and relevant
      biomarkers of renal function during the experiments. The experiments will be ended with a
      slow infusion of 1 L of Ringer´s acetate to dilute any raised oncotic pressure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of plasma volume expansion</measure>
    <time_frame>5 hours</time_frame>
    <description>Calculated by volume kinetics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in plasma oncotic pressure</measure>
    <time_frame>5 hours</time_frame>
    <description>Measured by oncometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Possible effect on biomarkers of kidney injury</measure>
    <time_frame>5 hours</time_frame>
    <description>Urinary albumin excretion (unit: mmol of albumin per mmol of urinary creatinine) and urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion (unit: µg/L per mmol of creatinine).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Half-life of plasma volume expansion</measure>
    <time_frame>5 hours</time_frame>
    <description>Calculated from the restoration of the diluted blood hemoglobnin concentration</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Unconscious</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Conscious healthy volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: intravenious infusion Drug: albumin 20%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery under general anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: intravenious infusion Drug: albumin 20%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-surgical inflammation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: intravenious infusion Drug: albumin 20%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Albumin 20%</intervention_name>
    <description>Intervention: intravenious infusion Drug: albumin</description>
    <arm_group_label>Conscious healthy volunteers</arm_group_label>
    <arm_group_label>Surgery under general anesthesia</arm_group_label>
    <arm_group_label>Post-surgical inflammation</arm_group_label>
    <other_name>Albumin in healthy volunteers</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers.

          -  Patients in ASA classes I-II scheduled for surgery.

        Exclusion Criteria:

          -  Expected major hemorrhage during surgery.

          -  Blood hemoglobin concentration of &lt; 10 g/dL.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert G Hahn, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Director, Södertälje sjukhus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert G Hahn, MD, PhD</last_name>
    <phone>0046 8 55024000</phone>
    <phone_ext>4670</phone_ext>
    <email>robert.hahn@sll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joachim Zdolsek, MD, PhD</last_name>
    <phone>00456 70 3031434</phone>
    <email>joachim.zdolsek@regionostergotland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joachim Zdolsek, MD, PhD</last_name>
      <phone>0046 70 3031434</phone>
      <email>joachim.zdolsek@regionostergotland.se</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>171 64</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Hedin A, Hahn RG. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci (Lond). 2005 Mar;108(3):217-24.</citation>
    <PMID>15538944</PMID>
  </reference>
  <reference>
    <citation>Woodcock TM, Woodcock TE. Revised Starling equation predicts pulmonary edema formation during fluid loading in the critically ill with presumed hypovolemia. Crit Care Med. 2012 Sep;40(9):2741-2; author reply 2742. doi: 10.1097/CCM.0b013e31825ae6c9.</citation>
    <PMID>22903119</PMID>
  </reference>
  <reference>
    <citation>Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010;14(5):R191. doi: 10.1186/cc9308. Epub 2010 Oct 28.</citation>
    <PMID>21029460</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2015</study_first_submitted>
  <study_first_submitted_qc>September 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2015</study_first_posted>
  <last_update_submitted>March 19, 2018</last_update_submitted>
  <last_update_submitted_qc>March 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sodertalje Hospital</investigator_affiliation>
    <investigator_full_name>Robert Hahn</investigator_full_name>
    <investigator_title>Research Dircetor</investigator_title>
  </responsible_party>
  <keyword>albumin</keyword>
  <keyword>surgery</keyword>
  <keyword>inflammation</keyword>
  <keyword>volume kinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>When the study is completed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

